100 |
226.0 |
Index |
5.2.3 |
5.0 |
CM |
Countermeasure Management |
16.0 |
CUE |
Countermeasure Utilization & Effectiveness |
The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention. |
M33 |
Percent of seniors age 65 and older in the state receiving a pneumococcal vaccination |
The measure focuses on adults aged 65+ who have ever had a pneumonia vaccination. The measure should be viewed alongside other measures in the Countermeasures Utilization Effectiveness sub-domain as an indicator of pre-event capacity of the state's immunization system. |
CDC BRFSS |
Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System Survey Questionnaire (BRFSS). Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Survey data analyzed by PMO personnel. |
2012—2017 |
The measure evaluates the recommended vaccine for preventable disease in seniors, and may not reflect the vaccination rate for a severe emerging disease. |